Decision Impact Trial of KidneyIntelX

Inclusion Criteria

• •23 years of age or older.
• •Clinical history of confirmed type 2 diabetes.
• •Evidence of DKD Stages 1-3:
• •Baseline eGFR of 30-60 ml/min/1.73m2 (confirmed 3 months apart with at least one value within 1 year prior to enrollment)
• •Individuals with eGFR ≥60 ml/min/1.73m2 and albuminuria (UACR ≥30mg/g)
• •All patients will have a HbA1c, eGFR, urine albumin and urine creatinine, eGFR, available from within 12 months of enrollment (to be obtained if not clinically available prior).
• •The subject must be able to comprehend and sign an approved informed consent form and other applicable study documents.